Amarin Corporation PLC
(NASDAQ:AMRN)|
0.71 0.00 (0.00%) Dec 04 - Close |
|
|
|
After-Hours 0.74 +0.03 (4.23%) Thu, 4 Dec 2008 7:40 PM
- Compare AMRN with:
- View: Line | Candlestick
Company Profile
Amarin Corporation PLC
110 Cannon Street
London, EC4N 6AR
England - Map
Phone: 44 2074999009
Fax: 44 2074999004
Website: www.amarincorp.com
CEO: Thomas G. Lynch
Employees: 25
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev/commercialize pharmaceutical products
The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
Recent news for AMRN
-
Video Interview: Thomas Lynch, Chairman and Chief Executive Officer, Amarin Corporation plc
GlobeNewswire - Nov 21 at 1:19 ET
-
Coverage initiated on Amarin by Rodman & Renshaw
Briefing.com - Nov 06 at 10:12 ET
-
Amarin to Present at 10th Annual Rodman & Renshaw Healthcare Conference
Business Wire - Nov 06 at 7:13 ET
-
Amarin CEO Featured on CEOcast.Com
Business Wire - Nov 05 at 7:30 ET
-
Amarin Appoints Dr. Lars Ekman as Non-Executive Director
Business Wire - Nov 03 at 8:05 ET
-
EDGAR Online Financials - Sep 30 at 8:04 ET
-
Amarin Corporation plc Q2 2008 Earnings Call Transcript
Seeking Alpha - Sep 25 at 10:47 ET
-
Amarin Earnings Call scheduled for 8:30 am ET today
CCBN - Sep 25 at 7:30 ET
-
Amarin Announces Financial Results for Second Quarter 2008
Business Wire - Sep 25 at 6:31 ET
-
Q2 2008 Amarin Earnings Release - Time Not Supplied
CCBN - Sep 25 at 6:07 ET